595
Views
24
CrossRef citations to date
0
Altmetric
Review

Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain

, , &
Pages 1009-1028 | Received 07 Jan 2020, Accepted 31 Jul 2020, Published online: 31 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Chanichon Chomchoei, James Michael Brimson & Sirikalaya Brimson. (2022) Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert Opinion on Therapeutic Targets 26:12, pages 1087-1097.
Read now
Mani Iyer Prasanth, Tewin Tencomnao & James Michael Brimson. (2021) The role of the sigma-1 receptor in neuroprotection: Comment on Nrf-2 as a therapeutic target in ischemic stroke. Expert Opinion on Therapeutic Targets 25:7, pages 613-614.
Read now
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, Sirikalaya Brimson, Premrutai Thitilertdecha & Tewin Tencomnao. (2021) Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy. Expert Opinion on Therapeutic Targets 25:6, pages 435-449.
Read now
Mani Iyer Prasanth, Dicson Sheeja Malar, Tewin Tencomnao & James Michael Brimson. (2021) The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s. Expert Opinion on Therapeutic Targets 25:5, pages 401-414.
Read now

Articles from other publishers (20)

Tao Wang & Hongmei Jia. (2023) The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy. International Journal of Molecular Sciences 24:15, pages 12025.
Crossref
Maria Dichiara, Francesca Alessandra Ambrosio, Carla Barbaraci, Rafael González-Cano, Giosuè Costa, Carmela Parenti, Agostino Marrazzo, Lorella Pasquinucci, Enrique J. Cobos, Stefano Alcaro & Emanuele Amata. (2023) Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands. ACS Chemical Neuroscience 14:10, pages 1845-1858.
Crossref
Dicson S. Malar, Premrutai Thitilertdecha, Kanokphorn S. Ruckvongacheep, Sirikalaya Brimson, Tewin Tencomnao & James M. Brimson. (2023) Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. CNS Drugs 37:5, pages 399-440.
Crossref
Jared VanderZwaag, Torin Halvorson, Kira Dolhan, Eva Šimončičová, Benneth Ben-Azu & Marie-Ève Tremblay. (2022) The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Neurochemical Research 48:4, pages 1129-1166.
Crossref
Britney N. Lizama, Jennifer Kahle, Susan M. Catalano, Anthony O. Caggiano, Michael Grundman & Mary E. Hamby. (2023) Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases. International Journal of Molecular Sciences 24:7, pages 6251.
Crossref
Yiran Xu, Shuxia Wang & Ping Zhu. (2023) Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer’s Disease and Parkinson's Disease. Current Stem Cell Research & Therapy 18:2, pages 154-162.
Crossref
Mikhail V. Voronin, Elena V. Abramova, Ekaterina R. Verbovaya, Yulia V. Vakhitova & Sergei B. Seredenin. (2023) Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection. International Journal of Molecular Sciences 24:1, pages 823.
Crossref
James Michael Brimson, Mani Iyer Prasanth, Discon Sheeja Malar, Kanika Verma, Waluga Plaingam & Tewin Tencomnao. (2022) Bacopa monnieri protects neuronal cell line and Caenorhabditis elegans models of Alzheimer’s disease through sigma-1 receptor antagonist sensitive and antioxidant pathways. Nutrition and Healthy Aging 7:3-4, pages 173-196.
Crossref
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, How Wan Leong, Yew Mun Chan, Zhi Ling Chan & Ethan Wei Jie Kong. (2022) Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease. Pharmaceuticals 15:12, pages 1560.
Crossref
Atul Kabra, Ruchika Garg, James Brimson, Jelena Živković, Saud Almawash, Muhammad Ayaz, Asif Nawaz, Syed Shams Ul Hassan & Simona Bungau. (2022) Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Frontiers in Pharmacology 13.
Crossref
Núria Gaja-Capdevila, Neus Hernández, Sandra Yeste, Raquel F. Reinoso, Javier Burgueño, Ana Montero, Manuel Merlos, José M. Vela, Mireia Herrando-Grabulosa & Xavier Navarro. (2022) EST79232 and EST79376, Two Novel Sigma-1 Receptor Ligands, Exert Neuroprotection on Models of Motoneuron Degeneration. International Journal of Molecular Sciences 23:12, pages 6737.
Crossref
Siu Wa Tang, Brian E. Leonard & Daiga Maret Helmeste. (2022) Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatrica 34:3, pages 109-126.
Crossref
Anna Sampietro, F. Javier Pérez-Areales, Paula Martínez, Elsa M. Arce, Carles Galdeano & Diego Muñoz-Torrero. (2022) Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis. Pharmaceuticals 15:5, pages 545.
Crossref
Belgin Sever, Halilibrahim Ciftci, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita & Ayşe Nazlı Başak. (2022) Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2400.
Crossref
Vladimir Zhemkov, Jonathon A Ditlev, Wan-Ru Lee, Mikaela Wilson, Jen Liou, Michael K Rosen & Ilya Bezprozvanny. (2021) The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains. eLife 10.
Crossref
Н.А. Красковская & И.Б. Безпрозванный. (2021) Нормализация кальциевого баланса в нейронах стриатума при болезни хантингтона: роль сигма-1-рецептора как потенциальной мишени для терапии. Биохимия 86:4, pages 554-563.
Crossref
Nina A. Kraskovskaya & Ilya B. Bezprozvanny. (2021) Normalization of Calcium Balance in Striatal Neurons in Huntington’s Disease: Sigma 1 Receptor as a Potential Target for Therapy. Biochemistry (Moscow) 86:4, pages 471-479.
Crossref
Luana Naia, Philip Ly, Sandra I. Mota, Carla Lopes, Carina Maranga, Patrícia Coelho, Noga Gershoni-Emek, Maria Ankarcrona, Michal Geva, Michael R. Hayden & A. Cristina Rego. (2021) The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models. Neurotherapeutics 18:2, pages 1017-1038.
Crossref
James M. Brimson, Sirikalaya Brimson, Mani Iyer Prasanth, Premrutai Thitilertdecha, Dicson Sheeja Malar & Tewin Tencomnao. (2021) The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data. Scientific Reports 11:1.
Crossref
SachchidaNand Rai, Payal Singh, Ritu Varshney, VivekK Chaturvedi, Emanuel Vamanu, MP Singh & BrijeshKumar Singh. (2021) Promising drug targets and associated therapeutic interventions in Parkinson’s disease. Neural Regeneration Research 16:9, pages 1730.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.